Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

262.67

-20.62 (-7.28%)

At close: Feb 19, 2026, 4:00 PM EST

260.08

-2.59 (-0.99%)

After-hours: Feb 19, 2026, 6:39 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Genetic Medicines to Treat Diseases with High Unmet Medical Needs	389.13M	290.52M	50.70M	-	-
Genetic Medicines to Treat Diseases with High Unmet Medical Needs Growth	33.94%	473.02%	-	-	-
Total	389.13M	290.52M	50.70M	-	-
Total Growth	33.94%	473.02%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	389.13M	290.52M	50.70M	-	-
United States Growth	33.94%	473.02%	-	-	-
Total	389.13M	290.52M	50.70M	-	-
Total Growth	33.94%	473.02%	-	-	-

Source: S&P Global Market Intelligence.